Diarylureas as Antitumor Agents

Catalano, Alessia and Iacopetta, Domenico and Sinicropi, Maria Stefania and Franchini, Carlo (2021) Diarylureas as Antitumor Agents. Applied Sciences, 11 (1). p. 374. ISSN 2076-3417

[thumbnail of applsci-11-00374.pdf] Text
applsci-11-00374.pdf - Published Version

Download (4MB)

Abstract

The diarylurea is a scaffold of great importance in medicinal chemistry as it is present in numerous heterocyclic compounds with antithrombotic, antimalarial, antibacterial, and anti-inflammatory properties. Some diarylureas, serine-threonine kinase or tyrosine kinase inhibitors, were recently reported in literature. The first to come into the market as an anticancer agent was sorafenib, followed by some others. In this review, we survey progress over the past 10 years in the development of new diarylureas as anticancer agents.

Item Type: Article
Subjects: EP Archives > Multidisciplinary
Depositing User: Managing Editor
Date Deposited: 16 Feb 2023 07:21
Last Modified: 17 Jun 2024 05:56
URI: http://research.send4journal.com/id/eprint/812

Actions (login required)

View Item
View Item